Back to search

United Kingdom· GB-APID-40022811000001107

Klisyri 10mg/g ointment 250mg sachets

A tirbanibulin product containing tirbanibulin, registered in United Kingdom by Almirall Ltd. The same ATC class is registered in 12 of our 19 countries.

ATC D06BX03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedKlisyri 10mg/g ointment 250mg sachetsATCD06BX03REGISTER NO.GB-APID-4002281100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Tirbanibulin is registered in 12 of 19 countries.

Countries holding a registration under ATC D06BX03 (tirbanibulin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Tirbanibulin · ATC D06BX03

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Tirbanibulin
Manufacturer
Almirall Ltd
Country
United Kingdom (GB)
ATC code
D06BX03
ATC class
Tirbanibulin
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    8430308132264

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tirbanibulin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tirbanibulin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Klisyri
  • Liechtenstein · Klisyri
  • Norway · Klisyri

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/447088a5-c87f-4c4c-ae88-559d7c12b434
GET /v1/drugs/447088a5-c87f-4c4c-ae88-559d7c12b434?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "40022811000001107",
  "desc": "Klisyri 10mg/g ointment 250mg sachets (Almirall Ltd)",
  "form": "Cutaneous ointment",
  "vpid": "40121411000001106",
  "source": "dmd",
  "vtm_id": "1144614001",
  "strength": "10 mg",
  "substance": "Tirbanibulin",
  "ingredient": "Tirbanibulin",
  "supplier_code": "13610411000001109"
}

See everything about tirbanibulin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.